AT300291T
Treating cancer using tetraethyl thiuram disulfide
Abstract
Use of an effective amount of thiuram disulfide and a heavy metal ion for the preparation of a medicament for treating established cancer in a mammal.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
44 members in 9 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 39212299 | United States of America | A | |
| 9927193 | United States of America | W |
Members44
| Document | Office | Kind | |
|---|---|---|---|
| CA2384059A1 | Canada | A1 | |
| WO0117522A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2025500A | Australia | A | |
| US2001016600A1 | United States of America | A1 | |
| CA2424761A1 | Canada | A1 | |
| WO0228349A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU9661001A | Australia | A | |
| EP1214063A1 | European Patent Office (EPO) | A1 | |
| WO0228349A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2003065026A1 | United States of America | A1 | |
| US6548540B2 | United States of America | B2 | |
| JP2003514769A | Japan | A | |
| US6589987B2 | United States of America | B2 | |
| EP1328267A2 | European Patent Office (EPO) | A2 | |
| US2003229064A1 | United States of America | A1 | |
| US2004019102A1 | United States of America | A1 | |
| US6706759B1 | United States of America | B1 | |
| JP2004525079A | Japan | A | |
| US2004171678A1 | United States of America | A1 | |
| CA2525829A1 | Canada | A1 | |
| WO2005009338A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2005009338A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2005096304A1 | United States of America | A1 | |
| AU782029B2 | Australia | B2 | |
| EP1214063B1 | European Patent Office (EPO) | B1 | |
| AT300291TThis record | Austria | T | |
| ATE300291T1 | Austria | T1 | |
| DE69926407D1 | Germany | D1 | |
| ES2244237T3 | Spain | T3 | |
| EP1622599A2 | European Patent Office (EPO) | A2 | |
| WO2006023714A2 | World Intellectual Property Organization (WIPO) | A2 | |
| EP1328267A4 | European Patent Office (EPO) | A4 | |
| DE69926407T2 | Germany | T2 | |
| AU2001296610B2 | Australia | B2 | |
| WO2006023714A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2007232692A1 | United States of America | A1 | |
| EP1328267B1 | European Patent Office (EPO) | B1 | |
| AT415158T | Austria | T | |
| ATE415158T1 | Austria | T1 | |
| DE60136730D1 | Germany | D1 | |
| JP4268801B2 | Japan | B2 | |
| EP1622599A4 | European Patent Office (EPO) | A4 | |
| CA2384059C | Canada | C | |
| US7816403B2 | United States of America | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 99963914
Titles2
- German
- BEHANDLUNG VON KREBS MIT TETRAETHYLTHIURAMDISULFID
- English
- TREATMENT OF CANCER WITH TETRAETHYLTHIURAMDISULFIDE
Classification
- CPC, 15
- A61K45/06
- A61K31/325
- A61K33/04
- A61K33/24
- A61K33/245
- A61K33/26
- A61K33/30
- A61K33/32
- A61K33/34
- A61K33/36
- A61K33/38
- A61K38/44
- C12Y116/03001
- A61P35/00
- A61K33/243
- IPC, 20
- A61K45 00
- A61K31 145
- A61K31 17
- A61K31 28
- A61K31 325
- A61K33 04
- A61K33 24
- A61K33 243
- A61K33 26
- A61K33 30
- A61K33 32
- A61K33 34
- A61K33 36
- A61K33 38
- A61K38 00
- A61K38 20
- A61K38 21
- A61K38 44
- A61K45 06
- A61P35 00